1-(1-Benzothiophen-4-yl) piperazin Hydrochloride CAS 913614-18-3 Pite > 98.0% (HPLC) Brexpiprazole Entèmedyè Faktori
Ruifu Chimik Pwovizyon pou Brexpiprazole Entèmedyè
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]tiofèn CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-yon CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3
Non Chimik | 1-(1-Benzothiophen-4-yl)piperazine Hydrochloride |
Sinonim | Brexpiprazole Entèmedyè 2;1-Benzo [b] Thien-4-yl-Piperazine Hydrochloride;1-Benzo [b] Thien-4-ylpiperazine Monohydrochloride |
Nimewo CAS | 913614-18-3 |
Nimewo CAT | RF-PI1034 |
Estati Stock | Nan stock, pwodiksyon kapasite 100MT/ane |
Fòmil molekilè | C12H15ClN2S |
Pwa molekilè | 254.7789 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan pou blan |
Idantifikasyon | Tan retansyon echantiyon an konfòm ak estanda referans lan |
Pite / Metòd analiz | >99.0% (HPLC) |
Pèt sou siye | <0.50% |
Dlo (KF) | <0.50% |
Rezid sou ignisyon | <0.20% |
Sibstans ki gen rapò | (HPLC) |
Nenpòt enpurte endividyèl | <0.50% |
Enpurte total | <1.00% |
Enfrawouj Spectrum | Konfòm ak estrikti |
Spectre proton RMN | Konfòm ak estrikti |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Brexpiprazole (CAS: 913611-97-9) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride (CAS: 913614-18-3) se yon entèmedyè nan Brexpiprazole (CAS: 913611-97-9).Brexpiprazole se yon kalite antipsikotik atipik.Li se yon agonist pasyèl reseptè dopamine D2.Kòm yon modilatè aktivite serotonin-dopamine roman, li ka itilize pou tretman eskizofreni, ak pou tretman adjunctive pou depresyon.Li kapab tou bay efikasite ak tolerans sou tretman adjunctive etabli yo nan maladi depresyon (MDD).Dwòg la montre yon pwofil famasi inik, aji kòm yon agonist pasyèl nan reseptè serotonin 5-HT1A ak dopamine D2 ak kòm yon antagonist konplè nan reseptè 5-HT2A ak noradrenalin α1B/2C, ak menm jan an afinite obligatwa subnanomolar.Dwòg la, ki te devlope pa Otsuka ak Lundbeck, te apwouve nan 2015 pa FDA a pou tretman an nan eskizofreni ak kòm yon tretman adjunctive pou depresyon.
-
1-(1-Benzothiophen-4-yl)piperazine Hydrochlorid...
-
Brexpiprazole CAS 913611-97-9 Pite > 99.0% (HP...
-
7-Hydroxyquinolinone CAS 70500-72-0 Pite> 98....
-
4-Bromobenzo[b]tiofèn CAS 5118-13-8 Pite >...
-
4-Chlorobenzo[b]thiophene CAS 66490-33-3 Pite...
-
7-(4-Chlorobutoxy)quinolin-2(1H)-yon CAS 913613...
-
7-Hydroxy-3,4-Dihydro-2(1H)-Quinolinone CAS 222...
-
1-(2,3-Dichlorophenyl)piperazin Hydrochloride...
-
1-(2-Methoxyphenyl)piperazine Hydrochloride CAS...
-
1-(Cyclopropylcarbonyl)piperazin Hydrochloride...
-
(R)-(-)-2-Methylpiperazine CAS 75336-86-6 Purit...
-
(R)-1-Boc-3-(Hydroxymethyl)piperazine CAS 27878...
-
(R)-1-Boc-3-Methylpiperazine CAS 163765-44-4 Pu...
-
(S)-(+)-2-Methylpiperazine CAS 74879-18-8 Purit...
-
(R)-1-N-Boc-2-Methylpiperazine CAS 170033-47-3...
-
(S)-1-Boc-3-Hydroxymethylpiperazine CAS 314741-...